News Story: Full Text
Sponsored By
Gleolan for brain tumors
Please Click On The Above Banner For More Details
Braintumor Website

 

Immunotherapies combine for triple threat against deadly brain cancer

Al's Comment:

 I love these kinds of projects.   I think the cure is going to be a combination of treatments that work together to eliminate the cancer. I doubt we will get a magic bullet single treatment that would do it.   The Anti-cd47 antibody is experimental which makes it hard to use in new combinations.  It has been shown to be safe and help somewhat in other cancers.   I am working on a change in the laws to allow drugs like that to be approved in a new pathway, called conditional approval, which would allow us to not only try combinations like this now, but it also requires that all of the people who used these conditionally approved drugs to be followed in a registry to see how the drug and combinations work so we can home in on the ultime cure decades sooner!


Posted on: 04/24/2020

Immunotherapies combine for triple threat against deadly brain cancer

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740